Regeneron Pharmaceuticals
Utility Patents
Last updated:
List of all Regeneron Pharmaceuticals patents 248 in total
| Status | Patent |
|---|---|
Grant | Utility: Genetically modified rodent with an inducible ACVR1 mutation in exon 7 that causes ectopic bone formation Filling date: 12 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Bispecific anti-CD28 .times. anti-CD22 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 26 Jul 2022 |
Grant | Utility: Metabolically optimized cell culture Filling date: 12 Sep 2025 Issue date: 19 Jul 2022 |
Grant | Utility: Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 12 Jul 2022 |
Grant | Utility: Anti-MSR1 antibodies and methods of use thereof Filling date: 12 Sep 2025 Issue date: 5 Jul 2022 |
Grant | Utility: Methods for evaluating suitability of a biochemical filter Filling date: 12 Sep 2025 Issue date: 5 Jul 2022 |
Grant | Utility: Taurine supplemented cell culture medium and methods of use Filling date: 12 Sep 2025 Issue date: 26 Apr 2022 |
Grant | Utility: Anti-VEGF protein compositions and methods for producing the same Filling date: 12 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody Filling date: 12 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Anti-NPR1 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Anti-VEGF protein compositions and methods for producing the same Filling date: 12 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Anti-PD-1 antibodies for treatment of lung cancer Filling date: 12 Sep 2025 Issue date: 5 Apr 2022 |
Grant | Utility: Human serum albumin in formulations Filling date: 12 Sep 2025 Issue date: 8 Feb 2022 |
Grant | Utility: Mice that make heavy chain antibodies Filling date: 12 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Genetically modified major histocompatibility complex mice Filling date: 12 Sep 2025 Issue date: 18 Jan 2022 |
Grant | Utility: Non-human animals expressing pH-sensitive immunoglobulin sequences Filling date: 12 Sep 2025 Issue date: 18 Jan 2022 |
Grant | Utility: Genetically modified major histocompatibility complex mice Filling date: 12 Sep 2025 Issue date: 11 Jan 2022 |
Grant | Utility: Compositions and methods for internalizing enzymes Filling date: 12 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Histidine engineered light chain antibodies and genetically modified non-human animals for generating same Filling date: 12 Sep 2025 Issue date: 7 Dec 2021 |
Grant | Utility: Multispecific antigen-binding molecules and uses thereof Filling date: 12 Sep 2025 Issue date: 7 Dec 2021 |
Grant | Utility: Non-human animals expressing humanized C1Q complex Filling date: 12 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: Humanized C5 animals Filling date: 12 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Anti-VEGF protein compositions and methods for producing the same Filling date: 12 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: Human antibodies to Fel d1 and methods of use thereof Filling date: 12 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: Readily isolated bispecific antibodies with native immunoglobulin format Filling date: 12 Sep 2025 Issue date: 9 Nov 2021 |
Grant | Utility: Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof Filling date: 12 Sep 2025 Issue date: 26 Oct 2021 |
Grant | Utility: Cas-ready mouse embryonic stem cells and mice and uses thereof Filling date: 12 Sep 2025 Issue date: 28 Sep 2021 |
Grant | Utility: Anti-Zika virus antibodies and methods of use Filling date: 12 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9) Filling date: 12 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Humanized IL-4 and IL-4Ra animals Filling date: 12 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Non-human animals that select for light chain variable regions that bind antigen Filling date: 12 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Methods for producing aflibercept in chemically defined media having reduced aflibercept variants Filling date: 12 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Humanized IL-6 and IL-6 receptor Filling date: 12 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: High concentration VEGF receptor fusion protein containing formulations Filling date: 12 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Non-human animals having a humanized lymphocyte-activation gene 3 Filling date: 12 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors Filling date: 12 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Anti-VEGF protein compositions and methods for producing the same Filling date: 12 Sep 2025 Issue date: 24 Aug 2021 |
Grant | Utility: Anti-VEGF protein compositions and methods for producing the same Filling date: 12 Sep 2025 Issue date: 24 Aug 2021 |
Grant | Utility: Cornulin (CRNN) variants and uses thereof Filling date: 12 Sep 2025 Issue date: 24 Aug 2021 |
Grant | Utility: Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies Filling date: 12 Sep 2025 Issue date: 24 Aug 2021 |
Grant | Utility: VEGF antagonist formulations suitable for intravitreal administration Filling date: 12 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: Efficient selectivity of recombinant proteins Filling date: 12 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumab Filling date: 12 Sep 2025 Issue date: 27 Jul 2021 |
Grant | Utility: Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof Filling date: 12 Sep 2025 Issue date: 27 Jul 2021 |
Grant | Utility: VEGF antagonist formulations suitable for intravitreal administration Filling date: 12 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Production cell line enhancers Filling date: 12 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Anti-TrkB monoclonal antibodies and methods of use Filling date: 12 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies Filling date: 12 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Anti-VEGF protein compositions and methods for producing the same Filling date: 12 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Genetically modified mice and engraftment Filling date: 12 Sep 2025 Issue date: 6 Jul 2021 |
Showing 1 to 50 of 248 patents.